Great Point Partners’s Alkermes ALKS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-50,000
Closed -$1.77M 43
2026
Q1
$1.77M Buy
+50,000
New +$1.55M 0.41% 40
2024
Q1
Sell
-875,044
Closed -$24.3M 36
2023
Q4
$24.3M Hold
875,044
4.14% 8
2023
Q3
$24.5M Buy
875,044
+463,591
+113% +$13.6M 4.46% 6
2023
Q2
$12.9M Buy
+411,453
New +$12.5M 2.52% 17
2023
Q1
Sell
-46,185
Closed -$1.21M 45
2022
Q4
$1.21M Sell
46,185
-461,315
-91% -$11M 0.24% 40
2022
Q3
$11.3M Buy
507,500
+145,864
+40% +$3.79M 2.73% 14
2022
Q2
$10.8M Buy
+361,636
New +$10.4M 2.58% 18

Other funds holding ALKS

Great Point Partners's ALKS Position: Q2 2026 in Review

Great Point Partners sold out of Alkermes (ALKS) in Q2 2026, closing a stake of 50,000 shares — an estimated $1.77M sold.

Great Point Partners first reported a position in ALKS in Q2 2022 and held it in 7 quarters. The position peaked at $24.5M in Q3 2023. 424 funds tracked by Wall St. Rank hold ALKS as of Q2 2026.

  • Great Point Partners reported no remaining Alkermes position as of Q2 2026 after selling out during the quarter.
  • Great Point Partners sold 50,000 Alkermes shares in Q2 2026, an estimated $1.77M.
  • Great Point Partners first reported a position in Alkermes in Q2 2022 and held it in 7 quarters.
  • Great Point Partners's Alkermes position peaked at $24.5M in Q3 2023.
  • 424 funds tracked by Wall St. Rank held Alkermes as of Q2 2026.

Based on Great Point Partners's 13F filing for Q2 2026, filed 14 Aug 2026.